Followers | 0 |
Posts | 2,008 |
Boards Moderated | 0 |
Alias Born | 03/12/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yesterday PR: Cannabis Global Provides Corporate Update Ahead of Key Developments
https://finance.yahoo.com/news/cannabis-global-provides-corporate-ahead-113000911.html
$MCTC
Yesterday $MCTC closed up 16.67 percent on Tuesday, April 28, 2020, on 66 percent of normal volume.
This is my premarket watchlist this morning $MCTC
Good morning $MCTC players
$PLYZ BABBBBY what a find.....
https://plyzertechnologies.com/2020/03/plyzer-technologies-spain-sl-signs-vitae-health-innovation-as-a-new-saas-customer-for-its-business-analytics-platform-plyzer-intelligence/
https://plyzertechnologies.com/2020/03/plyzer-technologies-spain-sl-signs-the-global-life-science-company-bioiberica-as-a-new-saas-customer-for-its-business-analytics-platform-plyzer-intelligence/
https://plyzertechnologies.com/2020/03/plyzer-technologies-spain-sl-signs-pharmaceutical-chiesi-spain-as-a-new-saas-client-for-its-business-intelligence-platform-plyzer-intelligence/
THE DD CONTINUES...
$CONC on watch
This may be a very huge development so far and we will look forward to updating it again soon. $MCTC
Agreed...as volume picks up here, the stock price should follow. $MCTC
It's 6 patents now!
In total, the Company has recently filed six patents on cannabinoid extraction technologies and delivery systems.
$MCTC recent key developments is HUGE:
Licensing agreement with leading California cannabis delivery service
First-to-market research underway on THC-V, which is often called the skinny Cannabinoid
Acquisition and integration of patent pending technologies pertaining to polymeric cannabinoid nanoparticles, hemp extract bioenhancement, and beverage delivery systems for hemp extracts
Commercial Launch of EZ Hemp Infusions: patent pending 100% water-soluble technology enabling ultra-low doses of hemp extracts and cannabinoids to be utilized without any use of chemicals, surfactants, emulsifiers or other chemical agents, enabling manufacturers to maintain 100% clean labels
Commercial Launch of Hemp You Can Feel™ line of sweeteners and coffee creamers: two low-calorie sweeteners, two organic natural sweeteners, and three powdered non-dairy creamers based on all-natural hemp infusions
Initial orders for sales and distribution of Hemp You Can Feel™ Coffee and drink product
Looking for bounce here after news out $MCTC closed down 10.0 percent on Monday, April 27, 2020, on 2.27 times normal volume.
$MCTC is a Nevada registered, fully reporting and audited publicly-traded company doing business as Cannabis Global, Inc.
$MCTC massive upside potential here
hidden gem here
gm $CLWD players
Thanks for sharing, Rambo! $MCTC
$MCTC solid positioning for CBD market that's why they stands out because it has a number of patents now under review with the USPTO for truly important innovations related to bioavailability, infusion, and isolation of cannabinoids, including THC, CBD, and THCV.
The company made major headlines this week on gettin approval on South Korea. Fair to see next week we could see another big week if we have latest development. This cat can't be kept in the bag much longer. $AGNPF
The timetable for an approved vaccine could be much longer than the initial treatments. But right now, a company like $AGNPF getting in touch with the FDA is gaining alot attention.
Before the coronavirus pandemic i have found that the company’s focus has been on a number of diseases including non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. It’s this last disease that has lead to the blossoming of a new, potential treatment for COVID-19 infected patients. $AGNPF
$AGNPF developments heading in the right direction for sure.
“This first human trial of Ifenprodil in COVID-19 patients is a major step forward with our new acute lung injury clinical research program,” said Christopher J. Moreau CEO of Algernon. “Positive Phase 2 data would be an important milestone as we continue to investigate Ifenprodil’s therapeutic potential as a treatment for COVID-19, in addition to advancing our idiopathic pulmonary fibrosis and chronic cough program.”
so far no covid-19 vaccine and yet $AGNPF has the potential game-changing treatment and potential for big breakout when they found it.
We are sitting on a goldmine here. Algernon announced that it received approval from the Ministry of Food and Drug Safety in South Korea $AGNPF
This level won't last long for sure $AGNPF
Thinking we should have a giant momo coming here soon IMHO $AGNPF
No doubt this biotech play is busy with good things here $AGNPF cautions that while it is preparing to begin a Phase 2 clinical trial shortly in South Korea, it is not making any express or implied claims that NP-120 (Ifenprodil) is an effective treatment for acute lung injury (ALI), the COVID-19 virus, or any other medical condition at this time.
Approval from the Ministry of Food and Drug Safety in South Korea is an indicator that $AGNPF is going to be a major global player battling the corona virus IMHO
Right now, thanks to COVID-19, biotech penny stocks such as $AGNPF is getting a spotlight by the investors. Hopefully Human trial in South Korea is getting positive outcome
Not only $AGNPF has it been presented to the US FDA, but A also has been working to advance Ifenprodil into multiple phase 2 human trials in Australia, Canada, and South Korea. HUGE BOOM COMING!
It seems Ifenprodil showed promise as a possible treatment for human
“This first human trial of Ifenprodil in COVID-19 patients is a major step forward with our new acute lung injury clinical research program,” said Christopher J. Moreau CEO of Algernon. “Positive Phase 2 data would be an important milestone as we continue to investigate Ifenprodil’s therapeutic potential as a treatment for COVID-19, in addition to advancing our idiopathic pulmonary fibrosis and chronic cough program.”
i'm getting ready to add more today
$AGNPF
For investors like me, the $AGNPF is my huge focus..I dont wanna miss a thing here.. and when you talk about timing and opportunity in the market, getting your eyes on the next potential company to break out is key. $AGNPF
Huge development here $AGNPF pleased to announce that it has received approval from the Ministry of Food and Drug Safety in South Korea, as well as ethics approval, for an investigator-led, Phase 2 COVID-19 clinical study of its re-purposed drug NP-120 (Ifenprodil), an NMDA receptor antagonist.
GREAT NEWS $AGNPF Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
https://finance.yahoo.com/news/algernon-receives-regulatory-ethics-approval-113010577.html
$AGNPF better get ready. Germany to launch COVID-19 vaccine trials too.
1.1 million shares traded today $AGNPF people starting to realize what kind of opportunity is here.
First comes volume then comes price. $AGNPF
Algernon Pharmaceuticals currently investigating the potential of ifenprodil, a drug . If successful, it could be mass distributed to the covid patients $AGNPF
“We are very excited about having the potential opportunity to transition this Ifenprodil COVID-19 trial into a Phase 3 study based on positive preliminary data,” said Christopher J. Moreau CEO of Algernon. “Pending approval, we would be included with only a small handful of companies globally working with a potential drug treatment at a Phase 3 level on this disease.”
Definitely something is brewing here
Looking forward to the future of this company